Literature DB >> 1346464

C1-esterase inhibitor substitution in sepsis.

C E Hack, H J Voerman, B Eisele, H O Keinecke, J H Nuijens, A J Eerenberg, A Ogilvie, R J Strack van Schijndel, U Delvos, L G Thijs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1346464     DOI： 10.1016/0140-6736(92)91705-d

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  12 in total

Review 1.  Biological activities of C1 inhibitor.

Authors:  Alvin E Davis; Pedro Mejia; Fengxin Lu
Journal:  Mol Immunol       Date:  2008-07-31       Impact factor: 4.407

Review 2.  Intensive care.

Authors:  S Sinclair; M Singer
Journal:  Postgrad Med J       Date:  1993-05       Impact factor: 2.401

Review 3.  The role of gut mucosal hypoperfusion in the pathogenesis of post-operative organ dysfunction.

Authors:  M G Mythen; A R Webb
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

Review 4.  C1 inhibitor: molecular and clinical aspects.

Authors:  Marco Cicardi; Lorenza Zingale; Andrea Zanichelli; Emanuela Pappalardo; Benedetta Cicardi
Journal:  Springer Semin Immunopathol       Date:  2005-11-11

Review 5.  Prevention and therapy of the adult respiratory distress syndrome.

Authors:  B Temmesfeld-Wollbrück; D Walmrath; F Grimminger; W Seeger
Journal:  Lung       Date:  1995       Impact factor: 2.584

Review 6.  Perspectives for the future.

Authors:  E F Mammen
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

Review 7.  C1-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2.

Authors:  C E Hack; A C Ogilvie; B Eisele; A J Eerenberg; J Wagstaff; L G Thijs
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

8.  Effects of C1 esterase inhibitor administration on intestinal functional capillary density, leukocyte adherence and mesenteric plasma extravasation during experimental endotoxemia.

Authors:  Christian Lehmann; Jürgen Birnbaum; Carsten Lührs; Oskar Rückbeil; Claudia Spies; Sabine Ziemer; Matthias Gründling; Dragan Pavlovic; Taras Usichenko; Michael Wendt; Wolfgang J Kox
Journal:  Intensive Care Med       Date:  2003-10-29       Impact factor: 17.440

Review 9.  Bench-to-bedside review: the role of C1-esterase inhibitor in sepsis and other critical illnesses.

Authors:  Mervyn Singer; Annie M Jones
Journal:  Crit Care       Date:  2011-01-26       Impact factor: 9.097

10.  A pilot study to evaluate the effects of C1 esterase inhibitor on the toxicity of high-dose interleukin 2.

Authors:  A C Ogilvie; J W Baars; A J Eerenberg; C E Hack; H M Pinedo; L G Thijs; J Wagstaff
Journal:  Br J Cancer       Date:  1994-03       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.